TDP1 and cancer: The hypothesis that Tdp1 is responsible for drug resistance in some cancers is supported by a number of studies: Tdp1 deficiency in Tdp1 knockout mice and in human cell lines with a mutation, which reduces the activity of this enzyme, leads to hypersensitivity to camptothecin or its derivatives [14,15,16].